Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
01/2006
01/04/2006EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants
01/04/2006CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
01/04/2006CN1717175A Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
01/04/2006CN1234347C Anti-virus composition
01/03/2006US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity
01/03/2006US6982331 Synthesis of chlorinated pyrimidines
01/03/2006US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy
01/03/2006US6982266 N-(4-indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}carboxamide for example; antiproliferative agents which inhibit phosphorylation of kinases such as tyrosine kinase; cancer, arteriosclerosis
01/03/2006US6982260 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
01/03/2006CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring
12/2005
12/29/2005WO2005123724A1 2,4-diaminoquinazolines for spinal muscular atrophy
12/29/2005WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
12/29/2005WO2005123697A1 Quinazoline derivatives
12/29/2005WO2005123696A1 Substituted quinazolones as anti-cancer agents
12/29/2005WO2005123695A1 Process for producing iminoquinazolinone derivative
12/29/2005WO2005123694A2 Quinazolinone compounds for the treatment of cough
12/29/2005WO2005123680A1 Six-membered heterocycles useful as serine protease inhibitors
12/29/2005WO2005123660A2 Polycationic compounds and uses thereof
12/29/2005WO2005123634A1 Fluorene derivative and organic electroluminescent device using same
12/29/2005WO2005123083A1 Compositions, devices and methods for treating cardiovascular disease
12/29/2005WO2005051974A3 Novel molecules for regulating cell death
12/29/2005WO2005047524A3 Compositions and methods for inducing cell dedifferentiation
12/29/2005US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin
12/29/2005US20050288318 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
12/29/2005US20050288314 2,4-diaminoquinazolines for spinal muscular atrophy
12/29/2005US20050288308 11B-HSD1 inhibitors for the treatment of diabetes
12/29/2005US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives
12/29/2005US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288297 {4-[6-methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl]piperazinyl}-N-[4-(methylethoxy)phenyl]carboxamide; inhibits phosphorylation of platelet-derived growth factor receptor to hinder abnormal cell growth/wandering; cancer; arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050288278 HIV replication inhibiting pyrimidines
12/29/2005DE102004027358A1 Pyrimidinverbindungen und ihre Verwendung Pyrimidine compounds and their use
12/29/2005CA2570248A1 Polycationic compounds and uses thereof
12/29/2005CA2568799A1 Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/28/2005EP1610126A1 A system for determining the electrical potential across a membrane
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta
12/28/2005EP1608622A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1714083A Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
12/28/2005CN1714079A Mandelic acid derivatives
12/28/2005CN1714060A Method for deuteration or tritiation of heterocyclic ring
12/27/2005US6979739 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
12/27/2005US6979695 Compounds capable of activating cholinergic receptors
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979566 Method of treatment of viral infection including HIV using water soluble fullerenes—III
12/27/2005CA2356325C Topical compositions comprising protected functional thiols
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005121107A1 Pyrazolo pyrimidines
12/22/2005WO2005121106A1 4-phenyl-pyrimidine-2-carbonitrile derivatives
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121095A1 Pyridine analogs as c5a antagonists
12/22/2005WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents
12/22/2005WO2005121073A1 Inhibitors of histone deacetylase
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005120510A1 Quinazolinone derivatives useful as vanilloid antagonists
12/22/2005WO2005082863A3 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
12/22/2005WO2005076854A3 Pyrimidinone compounds useful as kinase inhibitors
12/22/2005WO2005061443A3 Benzoyl-substituted phenylalanine amides
12/22/2005WO2004106296A3 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282847 Oxidizing a 4-substituted-2-thiopyrimidine and reacting the sulfone formed with an alkylcyanamide; both thio and sulfonyl intermediates of 4-substitutedaminopyridines are claimed, e.g., 4,6-dichloro-5-(2-chloro-6-fluorophenyl)-2-methylthiopyrimidine
12/22/2005US20050282846 Compounds capable of activating cholinergic receptors
12/22/2005US20050282839 Pyrimidyl phosphonate antiviral compounds and methods of use
12/22/2005US20050282838 Compounds, compositions, and methods
12/22/2005US20050282837 for use as anticancer agents and in treatment of herpes virus; packs/kits for plaque reduction
12/22/2005US20050282834 Compositions, devices and methods for treating cardiovascular disease
12/22/2005US20050282828 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
12/22/2005US20050282824 Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems
12/22/2005US20050282814 Vasculostatic agents and methods of use thereof
12/22/2005US20050282809 Heteroaryl-hydrazone compounds
12/22/2005US20050282802 double salts of N-(3-Methyl-benzylidene)-N'-[6-morpholin-4-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-hydrazine, having improved bioavailability, solubility, melting point and stability, used for the treatment of interleukin-12 (IL-12) related diseases or disorders
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005CA2727841A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2, 3-d] pyrimidine derivatives and related compounds
12/22/2005CA2569132A1 Cancer treatment method
12/22/2005CA2568722A1 Pyrazolo pyrimidines
12/22/2005CA2568673A1 Pyridine analogs as c5a antagonists
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2567845A1 4-phenyl-pyrimidine-2-carbonitrile derivatives
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2567821A1 Quinazolinone derivatives useful as vanilloid antagonists
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1607381A1 Process for producing tetraalkoxypropane and derivative thereof
12/21/2005EP1606271A1 Insecticidal phthalamide derivatives
12/21/2005EP1606265A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005CN1711249A Quinazolinone derivatives useful as anti-hyperalgesic agents
12/21/2005CN1711248A Pyrimidine-sulfamides and their use as endothelian receptor antagonist
12/21/2005CN1709876A 2-chloro-4,6-dimethoxy pyrimidine preparing method
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 427